Eupnoos

Eupnoos

Private
London, EnglandHealthcare & Life Scienceshttps://www.eupnoos.com

Last Round

Grant

Jul 11, 2024

Total Funding Raised

$5,400

Momentum Score

25 /100

Company Overview

Eupnoos is a UK-based medical technology company that transforms smartphones into clinical-grade screening tools for cardiopulmonary conditions. Using acoustic biomarkers, explainable AI, and the phone's built-in microphone, its platform analyzes breath sounds to detect and monitor respiratory diseases like asthma, Chronic Obstructive Pulmonary Disease (COPD), and heart failure. The company's mission is to improve respiratory health and address healthcare inequities by providing a low-cost, accessible, and personalized solution for early diagnosis and self-management, aiming to reduce the time from symptom onset to effective treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Non-AI

Keywords

clinical trial imagingmedical imaging managementclinical trial softwareimaging core lab softwareeClinical solutionsimaging data managementimaging CROmedical imaging SaaSimaging endpoint managementclinical trial workflowcontract research organizationsCROregulatory submission softwareFDA 21 CFR Part 11oncology trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eupnoos Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Eupnoos Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 11, 2024
GrantMay 20, 2022

Eupnoos Investors

Notable investors and investment history

InvestorRounds
KunsenGrant
NUS EnterpriseGrant
AstraZeneca SpainGrant
PIER71Grant

Eupnoos Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Eupnoos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Eupnoos's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range4
Year Founded2020
Last FundingJul 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.